Related Experiment Videos
Targeting cytotoxic T cells to antigen-specific B lymphocytes
European Journal of Immunology
|March 1, 1987
Summary
This study demonstrates bispecific antibodies can bridge T and B cells, enabling targeted depletion of specific B cells. This immunomanipulation approach shows potential for controlling B cell populations in vivo.
Area of Science:
- Immunology
- Immunotherapy
- Antibody Engineering
Background:
- Bispecific antibodies are emerging tools for immunomanipulation.
- Targeting cytotoxic T lymphocytes (CTL) to antigens via T cell receptor (TCR) engagement is a key strategy.
Purpose of the Study:
- To investigate the use of bispecific antibodies to bridge T and B cell receptors.
- To demonstrate the ability to deplete specific B cell populations using this method.
Main Methods:
- Conjugating F23.1 antibodies (TCR V beta 8 specific) with TNP (2,4,6-trinitrophenyl).
- Using the F23.1-TNP construct to bridge V beta 8+ T cells with TNP-specific B cells.
- Assessing B cell depletion in transgenic mice models.
Main Results:
- Demonstrated direct killing of TNP-specific B hybridomas and transgenic B cells.
- Showed specific depletion of Ig-secreting B cells from Sp6 transgenic mice using F23.1-TNP and CTLs.
- Confirmed successful bridging of T and B cell receptors.
Conclusions:
- Bispecific antibody conjugates can effectively link T cell receptors with specific antigens on B cells.
- This approach offers a theoretical basis for in vivo depletion or expansion of B cells based on their antigen specificity.